Product Images Doxazosin

This appears to be a medical study related to flow rate in men with benign prostatic hyperplasia (BPH). The study involved a treatment with doxazosin, which was titrated to a maximum dose of 8 mg, and compared with a placebo. The study evaluated the patients' maximum flow rate and symptom scores using a questionnaire. The study appears to have been conducted over several weeks on a total of 233 participants. The measurements taken in the study have been presented in tables. The text provides a summary of the study's findings, indicating that doxazosin at both 4 mg and 8 mg resulted in statistically significant improvement in maximum flow rate and symptom scores compared to the placebo.*

This is the description of a medical product, more specifically of doxazosin tablets, USP. No further information is available.*

This appears to be a product description including a product code (LO-V60-551E2), a customer service phone number (828-106909), and information about Doxazosin, which appears to be a medication available in tablet form. The text also includes some random letters and numbers such as "SOSHZO00000NLS," "U0 PNSUg|5e3," and "501 JRAND3."*

This is a label for a medication, Doxazosin, Tablets, USP. The label also contains various codes and phone numbers, but the text has a low quality and contains errors, making the information difficult to interpret.*